Structure and alignment of the membrane-associated antimicrobial peptide arenicin by oriented solid-state NMR spectroscopy. 2011

Evgeniy S Salnikov, and Christopher Aisenbrey, and Sergey V Balandin, and Maxim N Zhmak, and Tatiana V Ovchinnikova, and Burkhard Bechinger
UMR7177, Institut de Chimie, Université de Strasbourg/CNRS, 4, rue Blaise Pascal, 67070 Strasbourg, France.

The antimicrobial arenicin peptides are cationic amphipathic sequences that strongly interact with membranes. Through a cystine ring closure a cyclic β-sheet structure is formed in aqueous solution, which persists when interacting with model membranes. In order to investigate the conformation, interactions, dynamics, and topology of their bilayer-associated states, arenicin 1 and 2 were prepared by chemical solid-phase peptide synthesis or by bacterial overexpression, labeled selectively or uniformly with (15)N, reconstituted into oriented membranes, and investigated by proton-decoupled (31)P and (15)N solid-state NMR spectroscopy. Whereas the (31)P NMR spectra indicate that the peptide induces orientational disorder at the level of the phospholipid head groups, the (15)N chemical shift spectra agree well with a regular β-sheet conformation such as the one observed in micellar environments. In contrast, the data do not fit the twisted β-sheet structure found in aqueous buffer. Furthermore, the chemical shift distribution is indicative of considerable conformational and/or topological heterogeneity when at the same time the (15)N NMR spectra exclude alignments of the peptide where the β-sheet lies side ways on the membrane surface. The ensemble of experimental constraints, the amphipathic character of the peptide, and in particular the distribution of the six arginine residues are in agreement with a boatlike dimer structure, similar or related to the one observed in micellar solution, that floats on the membrane surface with the possibility to oligomerize into higher order structures and/or to insert in a transmembrane fashion.

UI MeSH Term Description Entries
D008051 Lipid Bilayers Layers of lipid molecules which are two molecules thick. Bilayer systems are frequently studied as models of biological membranes. Bilayers, Lipid,Bilayer, Lipid,Lipid Bilayer
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008823 Micelles Particles consisting of aggregates of molecules held loosely together by secondary bonds. The surface of micelles are usually comprised of amphiphatic compounds that are oriented in a way that minimizes the energy of interaction between the micelle and its environment. Liquids that contain large numbers of suspended micelles are referred to as EMULSIONS. Micelle
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D010743 Phospholipids Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system. Phosphatides,Phospholipid
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D011522 Protons Stable elementary particles having the smallest known positive charge, found in the nuclei of all elements. The proton mass is less than that of a neutron. A proton is the nucleus of the light hydrogen atom, i.e., the hydrogen ion. Hydrogen Ions,Hydrogen Ion,Ion, Hydrogen,Ions, Hydrogen,Proton
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA

Related Publications

Evgeniy S Salnikov, and Christopher Aisenbrey, and Sergey V Balandin, and Maxim N Zhmak, and Tatiana V Ovchinnikova, and Burkhard Bechinger
November 2004, Biochimica et biophysica acta,
Evgeniy S Salnikov, and Christopher Aisenbrey, and Sergey V Balandin, and Maxim N Zhmak, and Tatiana V Ovchinnikova, and Burkhard Bechinger
January 2009, Biophysical journal,
Evgeniy S Salnikov, and Christopher Aisenbrey, and Sergey V Balandin, and Maxim N Zhmak, and Tatiana V Ovchinnikova, and Burkhard Bechinger
October 2009, Solid state nuclear magnetic resonance,
Evgeniy S Salnikov, and Christopher Aisenbrey, and Sergey V Balandin, and Maxim N Zhmak, and Tatiana V Ovchinnikova, and Burkhard Bechinger
April 2007, European biophysics journal : EBJ,
Evgeniy S Salnikov, and Christopher Aisenbrey, and Sergey V Balandin, and Maxim N Zhmak, and Tatiana V Ovchinnikova, and Burkhard Bechinger
November 1995, Journal of biomolecular NMR,
Evgeniy S Salnikov, and Christopher Aisenbrey, and Sergey V Balandin, and Maxim N Zhmak, and Tatiana V Ovchinnikova, and Burkhard Bechinger
September 2006, Biochimica et biophysica acta,
Evgeniy S Salnikov, and Christopher Aisenbrey, and Sergey V Balandin, and Maxim N Zhmak, and Tatiana V Ovchinnikova, and Burkhard Bechinger
July 2007, Journal of the American Chemical Society,
Evgeniy S Salnikov, and Christopher Aisenbrey, and Sergey V Balandin, and Maxim N Zhmak, and Tatiana V Ovchinnikova, and Burkhard Bechinger
March 2009, Biophysical journal,
Evgeniy S Salnikov, and Christopher Aisenbrey, and Sergey V Balandin, and Maxim N Zhmak, and Tatiana V Ovchinnikova, and Burkhard Bechinger
September 2009, Proceedings of the National Academy of Sciences of the United States of America,
Evgeniy S Salnikov, and Christopher Aisenbrey, and Sergey V Balandin, and Maxim N Zhmak, and Tatiana V Ovchinnikova, and Burkhard Bechinger
April 2012, Chemistry and physics of lipids,
Copied contents to your clipboard!